Search results :

Eptifibatide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: B01AC16

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10
Cardiac failure congestive common, 5.1% 5.5% x x x x
Haemorrhage postmarketing, 0.02% - 19% 0% - 18.7% x x x x x x x x x x
Shock common, 2.6% 2.5% x x x x
Atrioventricular block common, 1.5% 1.3% x x x x
Headache 3.2% 3.2% x
Phlebitis common, 1.4% 1.5% x x x x
Ventricular fibrillation common, 1.3% 1.4% x x x x
Atrial fibrillation common, 0.288% 0.293% x x x x
Hypotension common, 0% 0.195% x x x x x x x x x x
Cardiac arrest common, 0.288% - 2.3% 0.391% - 2.7% x x x x
Body temperature increased 1.6% 1% x
Chest pain 0.8% - 2.12% 1.2% - 1.76% x
Pain 1.2% 1.2% x
Ventricular tachycardia common, 0.0962% - 1.1% 0.0977% - 1.1% x x x x
Nausea 1% 1% x
Abdominal pain 0.9% 1% x
Gastrointestinal haemorrhage 0.769% 0.0977% x
Haematoma 0.769% 0.293% x x
Haematuria 0.0962% - 1.35% 0% - 0.781% x x x
Arterial anomaly 0.673% 0.293% x
Retroperitoneal haemorrhage 0.673% 0.0977% x x x x x x x x
Cerebral ischaemia uncommon, 0.4% 0.5% x x x x
Haematemesis 0.0962% - 0.577% 0% - 0.391% x x x x x x x x x x
Coronary artery occlusion 0.288% 0.195% x
Dyspnoea 0.192% 0% x
Epistaxis 0.192% 0% x
Hypersensitivity 0.192% 0.0977% x x x x x x x x
Hypertension 0.192% 0% x
Cerebrovascular accident 0.192% 0.0977% x x x x x x x x
Haemorrhage intracranial 0.192% 0.0977% x x x x x x x x x x
Infection 0.0962% 0.0977% x
Dyspepsia 0.0962% 0.195% x
Myocardial infarction 0.0962% 0.488% x
Pericardial effusion 0.0962% 0.293% x
Pneumonia 0.0962% 0.195% x
Thrombophlebitis 0.0962% 0.0977% x
Coronary artery disease 0.0962% 0.0977% x
Thrombocytopenia postmarketing — 0.192% - 0.2% 0% - 0.1% x x x x x
Pulmonary haemorrhage postmarketing x x x x x x x x x
Anaphylactic shock very rare, postmarketing x x x x x x x x x
Rash very rare, postmarketing x x x
Urticaria very rare, postmarketing x x x x x x x
Trauma 0.02% 0% x
Cerebral infarction x x x x x x
Cardiac disorder x
Cardiac failure 0% 0.488% x
Blood disorder x
Immune system disorder x
Infarction x
Lymphoma x
Nervous system disorder x
Neuropathy peripheral x
Angiopathy x
Injection site reaction x
Unspecified disorder of skin and subcutaneous tissue x
Frank hematuria x x x x x x x
Haemorrhagic stroke x x x x x x x
Haematocrit decreased x
Blood and lymphatic system disorders x
Hepatic impairment x
Renal impairment x
Major bleed x x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

EPTIFIBATIDE / INTEGRILIN

Side effects:11
Source:FDA

Eptifibatide

Side effects:13
Source:FDA Structured Product Label

EPTIFIBATIDE / INTEGRILIN

Side effects:14
Source:FDA

eptifibatide / Integrilin

Side effects:14
Source:FDA

EPTIFIBATIDE / INTEGRILIN

Side effects:15
Source:FDA

eptifibatide / Integrilin

Side effects:16
Source:FDA

EPTIFIBATIDE / INTEGRILIN

Side effects:22
Source:Health Canada

eptifibatide / eptifibatide

Side effects:32
Source:EMA

Eptifibatide / INTEGRILIN INJECTION

Side effects:46
Source:medicines.org.au

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label